McKesson Corporation (MCK NYSE) stock market data APIs
$769.1202
-0.83(-0.1%)
as of June 8, 2026
Try our APIs with
free plan!
McKesson Corporation Financial Data Overview
Price chart is built with
Anychart
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Prev. Close
769.1202
Open
768.293
High
790.1018
Low
767.6449
52 wk Range
634.4232-997.8966
Market Cap
92 153 M
P/E Ratio
19.9594
Shares Outstanding
120 M
Revenue
403 430 M
EPS
11.69
Dividends (Yield)
0.0041
Beta
0.315
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with McKesson Corporation (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get McKesson Corporation data using free add-ons & libraries
Get McKesson Corporation Fundamental Data
McKesson Corporation Fundamental data includes:
- Net Revenue: 403 430 M
- EBITDA: 6 884 M
- Earnings Per Share: 38
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-05-07
- EPS/Forecast: 11.57
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
McKesson Corporation News
New
Tris Pharma Introduces a New 60 mL Bottle Size for DYANAVEL® XR (amphetamine) Extended-Release Oral Suspension CII
Tris Pharma, Inc. A new, smaller 60 mL bottle brings pharmacy-stocking and dosing convenience to a once-daily liquid amphetamine designed for individualized titration in ADHD MONMOUTH JUNCTION, N.J....
McKesson (MCK) Valuation Check After Recent Share Price Rebound And Mixed Fundamental Signals
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. McKesson stock reaction and recent performance snapshot ...
Here is What Analysts Are Saying About McKesson Corporation (MCK)
McKesson Corporation (NYSE:MCK) is one of top cheap stocks with Strong Buy ratings on Wall Street. Citi cut the price target on McKesson Corporation (NYSE:MCK) to $945 from $975 on May 14 and reiterat...
3 Cash-Producing Stocks with Promising Prospects
Businesses with strong free cash flow tend to be more adaptable and resilient. Some of these companies shine bright by using their cash wisely to strengthen their market positions. Not all companies ...
Get McKesson Corporation fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
